BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17643331)

  • 21. Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase.
    Riehman K; Crews C; Fridovich-Keil JL
    J Biol Chem; 2001 Apr; 276(14):10634-40. PubMed ID: 11152465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galactosemia: alterations in sulfate metabolism secondary to galactose-1-phosphate uridyltransferase deficiency.
    Tedesco TA; Miller KL
    Science; 1979 Sep; 205(4413):1395-7. PubMed ID: 472754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From gene to disease; galactosemia and galactose-1-phosphate uridyltransferase deficiency].
    Bosch AM; Waterham HR; Bakker HD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):80-1. PubMed ID: 14753129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and functional studies reveal a novel noncoding variant in GALT associated with a false positive newborn screening result for galactosemia.
    Liu Y; Sidhu A; Bean LH; Conway RL; Fridovich-Keil JL
    Clin Chim Acta; 2015 Jun; 446():171-4. PubMed ID: 25920691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-mediated attenuation of insulin-like growth factor-1 activity by galactose-1-phosphate in neonate skin fibroblast cultures: Galactosemia pathogenesis.
    Al-Essa M; Dhaunsi G
    Adv Clin Exp Med; 2020 Apr; 29(4):499-504. PubMed ID: 32356415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of galactose-1-phosphate uridyltransferase enzyme activity by liquid chromatography-tandem mass spectrometry.
    Li Y; Ptolemy AS; Harmonay L; Kellogg M; Berry GT
    Clin Chem; 2010 May; 56(5):772-80. PubMed ID: 20348403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unfolded protein response has a protective role in yeast models of classic galactosemia.
    De-Souza EA; Pimentel FS; Machado CM; Martins LS; da-Silva WS; Montero-Lomelí M; Masuda CA
    Dis Model Mech; 2014 Jan; 7(1):55-61. PubMed ID: 24077966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingolipid depletion suppresses UPR activation and promotes galactose hypersensitivity in yeast models of classic galactosemia.
    Pimentel FSA; Machado CM; De-Souza EA; Fernandes CM; De-Queiroz ALFV; Silva GFS; Del Poeta M; Montero-Lomeli M; Masuda CA
    Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166389. PubMed ID: 35301088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory effects of galactose on galactose-1-phosphate uridyltransferase activity on human hepatoblastoma HepG2 cells.
    Davit-Spraul A; Pourci ML; Ng KH; Soni T; Lemonnier A
    FEBS Lett; 1994 Nov; 354(2):232-6. PubMed ID: 7957929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.
    Tang M; Siddiqi A; Witt B; Yuzyuk T; Johnson B; Fraser N; Chen W; Rascon R; Yin X; Goli H; Bodamer OA; Lai K
    Eur J Hum Genet; 2014 Oct; 22(10):1172-9. PubMed ID: 24549051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography.
    Lindhout M; Rubio-Gozalbo ME; Bakker JA; Bierau J
    Clin Chim Acta; 2010 Jul; 411(13-14):980-3. PubMed ID: 20359473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular basis of galactosemia - Past, present and future.
    Timson DJ
    Gene; 2016 Sep; 589(2):133-41. PubMed ID: 26143117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase.
    Reichardt JK; Woo SL
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2633-7. PubMed ID: 2011574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal diagnosis of galactose-1-phosphate uridyltransferase (GALT)-deficient galactosemia.
    Elsas LJ
    Prenat Diagn; 2001 Apr; 21(4):302-3. PubMed ID: 11288121
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal of aberrant PI3K/Akt signaling by Salubrinal in a GalT-deficient mouse model.
    Balakrishnan B; Nicholas C; Siddiqi A; Chen W; Bales E; Feng M; Johnson J; Lai K
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3286-3293. PubMed ID: 28844959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hereditary galactosemia in rats: biochemical mechanisms of the disease].
    Solov'eva NA; Kandaurov VA; Zaĭdman AM; Salganik RI
    Vopr Med Khim; 1982; 28(3):15-21. PubMed ID: 6213094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulation of the Interactions of Arginine with Wild-Type GALT Enzyme and the Classic Galactosemia-Related Mutant p.Q188R by a Computational Approach.
    Verdino A; D'Urso G; Tammone C; Scafuri B; Catapano L; Marabotti A
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired NADPH oxidase activity in peripheral blood lymphocytes of galactosemia patients.
    Al-Essa M; Dhaunsi GS; Al-Qabandi W; Khan I
    Exp Biol Med (Maywood); 2013 Jul; 238(7):779-86. PubMed ID: 23828587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiochemical assay of minute quantities of galactose-1-phosphate uridyltransferase activity in erythrocytes and leukocytes of galactosemia patients.
    Xu YK; Kaufman FR; Donnell GN; Ng WG
    Clin Chim Acta; 1995 Mar; 235(2):125-36. PubMed ID: 7554267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency.
    Ornstein KS; McGuire EJ; Berry GT; Roth S; Segal S
    Pediatr Res; 1992 May; 31(5):508-11. PubMed ID: 1603629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.